Zpráva o průběhu klinického hodnocení Annual Report KDO_DC1311 za období 10. září 2022 ‒ 9. září 2023
| Title in English | Progress Report of the clinical evaluation Annual Report KDO_DC1311 for the period September 10, 2022 - September 9, 2023 |
|---|---|
| Authors | |
| Year of publication | 2023 |
| MU Faculty or unit | |
| Web | KDO_DC1311 |
| Description | The annual report gives the overview of the conduct of the clinical trial „Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors“. The primary aim of the clinical trial is to study the safety of inovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor. |
| Related projects: |